Rekombinanter B7-H2 (Prezalumab Biosimilar) Antikörper
Reaktivität: Human
FACS, SPR, Func, ELISA, BLI
Wirt: Human
Monoclonal
unconjugated
Recombinant Antibody
-
- Target Alle B7-H2 (Prezalumab Biosimilar) Produkte
- B7-H2 (Prezalumab Biosimilar)
- Antikörpertyp
- Recombinant Antibody
- Reaktivität
- Human
-
Wirt
-
Human
- Expressionssystem
- CHO Cells
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser B7-H2 (Prezalumab Biosimilar) Antikörper ist unkonjugiert
- Applikation
- Flow Cytometry (FACS), Surface Plasmon Resonance (SPR), Functional Studies (Func), ELISA, Bio-Layer Interferometry (BLI)
- Verwendungszweck
- Anti-B7-H2 / ICOSL / CD275 Reference Antibody (prezalumab)
- Sequenz
- EVQLVESGGG LVQPGGSLRL SCAASGFTFS SYWMSWVRQA PGKGLEWVAY IKQDGNEKYY VDSVKGRFTI SRDNAKNSLY LQMNSLRAED TAVYYCAREG ILWFGDLPTF WGQGTLVTVS SASTKGPSVF PLAPCSRSTS ESTAALGCLV KDYFPEPVTV SWNSGALTSG VHTFPAVLQS SGLYSLSSVV TVPSSNFGTQ TYTCNVDHKP SNTKVDKTVE RKCCVECPPC PAPPVAGPSV FLFPPKPKDT LMISRTPEVT CVVVDVSHED PEVQFNWYVD GVEVHNAKTK PREEQFNSTF RVVSVLTVVH QDWLNGKEYK CKVSNKGLPA PIEKTISKTK GQPREPQVYT LPPSREEMTK NQVSLTCLVK GFYPSDIAVE WESNGQPENN YKTTPPMLDS DGSFFLYSKL TVDKSRWQQG NVFSCSVMHE ALHNHYTQKS LSLSPGK,DIQMTQSPSS LSASVGDRVT ITCRASQGIS NWLAWYQQKP EKAPKSLIYA ASSLQSGVPS RFSGSGSGTD FTLTISSLQP EDFATYYCQQ YDSYPRTFGQ GTKVEIKRTV AAPSVFIFPP SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC
- Produktmerkmale
- Anti-B7-H2 / ICOSL / CD275 Reference Antibody (prezalumab) is expressed from CHO. The heavy chain type is huIgG2, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.
- Reinheit
- >95 %
- Isotyp
- IgG2SA
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Kommentare
-
Therapeutic Agents by Target and Mechanism: ICOS Ligand inhibitors
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Konzentration
- 1 mg/mL
- Buffer
- 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2
- Lagerung
- 4 °C,-80 °C
- Informationen zur Lagerung
- +4°C,-80°C
-
- Target
- B7-H2 (Prezalumab Biosimilar)
- Abstract
- B7-H2 (Prezalumab Biosimilar) Produkte
- Substanzklasse
- Biosimilar
- Molekulargewicht
- 145.5 kDa
- UniProt
- O75144
-
Sie sind hier:
